Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves

Biomaterials

Volumn 28, Issue 18, 2007, Pages 2861-2868

  Raghavan, Devanathan ^a   Simionescu, Dan T ^a   Vyavahare, Naren R ^a  

^a South   (United States)

Author keywords

GAGs; Hexosamine; Neomycin; Porcine aortic valves; Valve fixation

Indexed keywords

ENZYMATIC DEGRADATION; GLYCOSAMINOGLYCANS (GAG); HEXOSAMINE; PORCINE AORTIC VALVES; VALVE FIXATION;

ANTIBIOTICS; BLOOD VESSELS; CROSSLINKING; DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY;

HEART VALVE PROSTHESES;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; CYANAMIDE; ENZYME INHIBITOR; GLUTARALDEHYDE; HYALURONIDASE; N HYDROXYSUCCINIMIDE; NEOMYCIN TRISULFATE; SUCCINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; CROSS LINKING; DENATURATION; DIFFERENTIAL SCANNING CALORIMETRY; ENZYME DEGRADATION; HEART VALVE; HEART VALVE PROSTHESIS; IMPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS FIXATION; RAT;

ANIMALS; CALCIUM; CALORIMETRY, DIFFERENTIAL SCANNING; COLLAGEN; ELECTROPHORESIS; GLUTARAL; GLYCOSAMINOGLYCANS; HEART VALVE PROSTHESIS; HYALURONOGLUCOSAMINIDASE; IMMUNOHISTOCHEMISTRY; NEOMYCIN; RATS; SWINE; TEMPERATURE;

RATTUS; SUS;

EID: 33947591278     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.02.017     Document Type: Article

References (27)

1. Schoen F.J., and Levy R.J. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79 3 (2005) 1072-1080
2. Everaerts F., Torrianni M., van Luyn M., van Wachem P., Feijen J., and Hendriks M. Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method. Biomaterials 25 24 (2004) 5523-5530
3. Schoen FJ, Levy RJ. Founder's award, 25th annual meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999;47(4):439-65.
4. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis 12 2 (2003) 226-234
5. Vyavahare N., Ogle M., Schoen F.J., Zand R., Gloeckner D.C., Sacks M., et al. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 46 1 (1999) 44-50
6. Lovekamp J.J., Simionescu D.T., Mercuri J.J., Zubiate B., Sacks M.S., and Vyavahare N.R. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 27 8 (2006) 1507-1518
7. Mercuri J.J., Lovekamp J.J., Simionescu D.T., and Vyavahare N.R. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials 28 3 (2007) 496-503
8. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A 66 4 (2003) 755-763
9. Lovekamp J., and Vyavahare N. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves. J Biomed Mater Res 56 4 (2001) 478-486
10. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 12 2 (2003) 217-225
11. Elson L.A., and Morgan W.T. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 27 6 (1933) 1824-1828
12. Farndale R.W., Sayers C.A., and Barrett A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9 4 (1982) 247-248
13. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 2 (1986) 173-177
14. Hoemann C.D., Sun J., Chrzanowski V., and Buschmann M.D. A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300 1 (2002) 1-10
15. Pieper J.S., Oosterhof A., Dijkstra P.J., Veerkamp J.H., and van Kuppevelt T.H. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 20 9 (1999) 847-858
16. Vyavahare N., Hirsch D., Lerner E., Baskin J.Z., Schoen F.J., Bianco R., et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 95 2 (1997) 479-488
17. Simionescu D.T. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther 4 12 (2004) 1971-1985
18. Neame P.J., and Barry F.P. The link proteins. Exs 70 (1994) 53-72
19. Quinn T.M., Dierickx P., and Grodzinsky A.J. Glycosaminoglycan network geometry may contribute to anisotropic hydraulic permeability in cartilage under compression. J Biomech 34 11 (2001) 1483-1490
20. Claassen H., Cellarius C., Scholz-Ahrens K.E., Schrezenmeir J., Gluer C.C., Schunke M., et al. Extracellular matrix changes in knee joint cartilage following bone-active drug treatment. Cell Tissue Res (2006) 1-11
21. Salmen S., Hoechstetter J., Kasbauer C., Paper D.H., Bernhardt G., and Buschauer A. Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae. Planta Med 71 8 (2005) 727-732
22. Zhong S.P., Campoccia D., Doherty P.J., Williams R.L., Benedetti L., and Williams D.F. Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials 15 5 (1994) 359-365
23. Menzel E.J., and Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 131 1 (1998) 3-11
24. Jorge-Herrero E., Fernandez P., Gutierrez M., and Castillo-Olivares J.L. Study of the calcification of bovine pericardium: analysis of the implication of lipids and proteoglycans. Biomaterials 12 7 (1991) 683-689
25. Ohri R., Hahn S.K., Hoffman A.S., Stayton P.S., and Giachelli C.M. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium. J Biomed Mater Res A 70 2 (2004) 328-334
26. Grande-Allen K.J., Mako W.J., Calabro A., Shi Y., Ratliff N.B., and Vesely I. Loss of chondroitin 6-sulfate and hyaluronan from failed porcine bioprosthetic valves. J Biomed Mater Res A 65 2 (2003) 251-259
27. Mako W.J., et al. Loss of glycosaminoglycans (GAGs) from implanted bioprosthetic heart valves. Circulation 155 (1997) 863